feed,title,long_url,short_url
Benzinga,"TCR2 Therapeutics Shares Jump After Additional Reponses in Ovarian Cancer, Mesothelioma",https://benzinga.com/general/biotech/22/09/29049446/tcr2-therapeutics-shares-jump-after-additional-reponses-in-ovarian-cancer-mesothelioma,https://bit.ly/3feXaYb
